Dr. shalini singh
Dr. ARUN KUMAR SHARMA
Abstract
Purpose:
To compare intracameral Ropivacaine to Lignocaine during phacoemulsification under augmented topical anesthesia, in terms of efficacy and safety.
Methods:
184 subjects were planned for phacoemulsification under augmented topical anesthesia. subjects were randomized in Group A (Ropivacaine 0.1%) or Group B (Lignocaine 1.0%)and “The pain experienced by the patients during the surgery, mydriasis, post-op inflammation and endothelial cell change at six weeks” after the procedure was evaluated.
Results:
No significant difference was seen with respect to Age, painful surgical steps, visual analog scale scores, surgeon’s score, post-op inflammation, average ultrasound time during phaco. Subjects in Group A fared better when compared to Group B with respect to endothelial cell loss (P = 0.0008), and augmentation in mydriasis (P < 0.001). Conclusion: Intracameral Ropivacaine is superior to Lignocaine with regards to corneal endothelial cell safety, and augmenting mydriasis.


Leave a Comment